Founded in 2020, Overland Pharmaceuticals is establishing a leading cross-border platform company focused on advanced modalities through strategic partnering and in-house R&D. Overland is seeded by Hillhouse Capital with access to global innovation and China biopharma ecosystem. Overland is building an initial oncology portfolio of first-in-class ADC and allogeneic cell therapy programs for greater China and Asia through partnering with established biotechs. Through formative R&D partnerships and in-house technology platforms, Overland will move forward the development and commercialization of the most promising advances in medicine.
View Top Employees from Overland PharmaceuticalsWebsite | http://www.overlandpharma.com |
Revenue | $11 million |
Employees | 42 (34 on RocketReach) |
Founded | 2020 |
Phone | (508) 827-8686 |
Industry | Biotechnology Research, Pharmaceuticals, Healthcare |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Overland Pharmaceuticals employee's phone or email?
The Overland Pharmaceuticals annual revenue was $11 million in 2024.
Ed Zhang is the Co-Founder and Chief Executive Officer of Overland Pharmaceuticals.
34 people are employed at Overland Pharmaceuticals.
The NAICS codes for Overland Pharmaceuticals are [325, 32].
The SIC codes for Overland Pharmaceuticals are [28, 283].